LeBrasseur NK - Search Results

1

Myostatin and sarcopenia: opportunities and challenges - a mini-review.

White TA, LeBrasseur NK. White TA, et al. Among authors: lebrasseur nk. Gerontology. 2014;60(4):289-93. doi: 10.1159/000356740. Epub 2014 Jan 17. Gerontology. 2014. PMID: 24457615 Review.

2

Metabolic benefits of resistance training and fast glycolytic skeletal muscle.

LeBrasseur NK, Walsh K, Arany Z. LeBrasseur NK, et al. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E3-10. doi: 10.1152/ajpendo.00512.2010. Epub 2010 Nov 2. Am J Physiol Endocrinol Metab. 2011. PMID: 21045171 Free PMC article. Review.

3

Building muscle, browning fat and preventing obesity by inhibiting myostatin.

Lebrasseur NK. Lebrasseur NK. Diabetologia. 2012 Jan;55(1):13-7. doi: 10.1007/s00125-011-2361-8. Epub 2011 Nov 6. Diabetologia. 2012. PMID: 22057197

4

Preclinical studies on neurobehavioral and neuromuscular effects of cocaine hydrolase gene therapy in mice.

Murthy V, Gao Y, Geng L, LeBrasseur N, White T, Brimijoin S. Murthy V, et al. J Mol Neurosci. 2014 Jul;53(3):409-16. doi: 10.1007/s12031-013-0130-5. Epub 2013 Oct 2. J Mol Neurosci. 2014. PMID: 24085526 Free PMC article.

5

Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles.

List EO, Berryman DE, Funk K, Jara A, Kelder B, Wang F, Stout MB, Zhi X, Sun L, White TA, LeBrasseur NK, Pirtskhalava T, Tchkonia T, Jensen EA, Zhang W, Masternak MM, Kirkland JL, Miller RA, Bartke A, Kopchick JJ. List EO, et al. Among authors: lebrasseur nk. Endocrinology. 2014 May;155(5):1793-805. doi: 10.1210/en.2013-2086. Epub 2014 Feb 11. Endocrinology. 2014. PMID: 24517230 Free PMC article.

6

Regenerating skeletal muscle in the face of aging and disease.

Jasuja R, LeBrasseur NK. Jasuja R, et al. Among authors: lebrasseur nk. Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S88-96. doi: 10.1097/PHM.0000000000000118. Am J Phys Med Rehabil. 2014. PMID: 24879554 Review.

7

Physiologic and metabolic safety of butyrylcholinesterase gene therapy in mice.

Murthy V, Gao Y, Geng L, LeBrasseur NK, White TA, Parks RJ, Brimijoin S. Murthy V, et al. Among authors: lebrasseur nk. Vaccine. 2014 Jul 16;32(33):4155-62. doi: 10.1016/j.vaccine.2014.05.067. Epub 2014 Jun 2. Vaccine. 2014. PMID: 24892251 Free PMC article.

8

TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.

Idrissova L, Malhi H, Werneburg NW, LeBrasseur NK, Bronk SF, Fingas C, Tchkonia T, Pirtskhalava T, White TA, Stout MB, Hirsova P, Krishnan A, Liedtke C, Trautwein C, Finnberg N, El-Deiry WS, Kirkland JL, Gores GJ. Idrissova L, et al. Among authors: lebrasseur nk. J Hepatol. 2015 May;62(5):1156-63. doi: 10.1016/j.jhep.2014.11.033. Epub 2014 Nov 28. J Hepatol. 2015. PMID: 25445398 Free PMC article.

9

Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.

McGee-Lawrence ME, White TA, LeBrasseur NK, Westendorf JJ. McGee-Lawrence ME, et al. Among authors: lebrasseur nk. Mol Cell Endocrinol. 2015 Jul 15;410:42-51. doi: 10.1016/j.mce.2015.02.001. Epub 2015 Feb 7. Mol Cell Endocrinol. 2015. PMID: 25666992 Free PMC article. Review.

10

Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay.

Bergen HR 3rd, Farr JN, Vanderboom PM, Atkinson EJ, White TA, Singh RJ, Khosla S, LeBrasseur NK. Bergen HR 3rd, et al. Among authors: lebrasseur nk. Skelet Muscle. 2015 Jul 15;5:21. doi: 10.1186/s13395-015-0047-5. eCollection 2015. Skelet Muscle. 2015. PMID: 26180626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters